Correction to “Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4-mediated cell death in TP53-deficient ALL” - Poll - MDSpire

Erratum for “Simultaneous Targeting of De Novo Pyrimidine Synthesis and ATR Enhances ATF4-Driven Apoptosis in TP53-Deficient Acute Lymphoblastic Leukemia”

October 5, 2026

Hemasphere

Share

Original Source(s)

Hemasphere

Correction to “Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4-mediated cell death in TP53-deficient ALL”

October 5, 2026

Related Content

World Journal Of Urology

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation

by J. Gómez Rivas, L. Fernández Hernández, L. Turpin, A. Peyrottes, M. Rouprêt
September 29, 2026

Jama Internal Medicine

Errors in Discussion and References

October 1, 2026

Bmc Cancer

Correction: Survival of myelodysplastic syndrome patients after azacitidine therapy

by Kanticha Thammagul, Suppalux Limpiwattakee, Pichika Chantrathammachart, Teeraya Puavilai, Suporn Chuncharunee, Pimjai Niparuck
September 26, 2026